Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, Molecular therapy for Pulmonary Hypertension: p63 and p73 inhibit pulmonary hypertension via up regulation of their target genes, 17/January/2015, 14.16, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance: This study suggests, for the first time, that p63 and p73, by increasing the expression of their target genes, they may inhibit pulmonary hypertension. Thus, pharmacological formulations encompassing “p73 and p63 activators” may be used to treat pulmonary hypertension.
Amount: $ 300
Undisclosed information: How p63 and p73 inhibit the development of pulmonary hypertension
Courtesy: When you cite drop us a line at email@example.com